Find stats on top websites
Industry Landscape
The healthcare technology industry, particularly in pharmacy services, is experiencing rapid transformation driven by digitalization, automation, and a focus on value-based care. Independent pharmacies face pressure from declining reimbursements and administrative burdens, leading to increased adoption of solutions that enhance efficiency, profitability, and patient outcomes. Integration and real-time data are becoming critical for streamlining workflows and optimizing medication management.
Total Assets Under Management (AUM)
Total Prescription Drug Spending in United States
~$378 billion (2022)
(2.8% CAGR)
- Increased utilization of prescription drugs.
- Rising drug prices, though moderated by generic use.
- Growing chronic disease prevalence impacting demand.
Total Addressable Market
Approximately $380 billion
Market Growth Stage
Pace of Market Growth
Emerging Technologies
AI-Powered Predictive Analytics
Utilizing artificial intelligence and machine learning to forecast prescription trends, patient adherence, and optimal drug pricing, leading to more proactive and personalized pharmacy services.
Blockchain for Supply Chain & Data Security
Implementing distributed ledger technology to enhance transparency, traceability, and security of pharmaceutical supply chains and patient data, reducing fraud and improving trust.
Interoperable FHIR APIs
Standardizing healthcare data exchange through Fast Healthcare Interoperability Resources (FHIR) APIs to enable seamless, real-time communication between diverse healthcare IT systems.
Impactful Policy Frameworks
21st Century Cures Act (2016) - Information Blocking Rule (effective 2021)
This rule, stemming from the 21st Century Cures Act, prohibits healthcare providers, IT developers, and health information exchanges from engaging in practices that are likely to interfere with the access, exchange, or use of electronic health information (EHI).
This policy mandates greater data transparency and interoperability, directly benefiting EZSCRIPTRx by facilitating easier integration with various EHR and pharmacy management systems and enabling richer data access.
CMS Interoperability and Patient Access Final Rule (CMS-9115-F, 2020)
This rule requires certain payers (Medicare Advantage, Medicaid, CHIP, and Qualified Health Plans on the Federal Exchange) to implement APIs to make patient claims and encounter data, including pharmacy data, accessible to patients and third-party applications.
The rule pushes for greater data liquidity, providing EZSCRIPTRx with enhanced access to real-time patient-specific benefit information from a wider array of health plans, which is crucial for its iRTBV offering.
No Surprises Act (2020)
The No Surprises Act protects consumers from surprise medical bills for emergency services and certain non-emergency services, including out-of-network services at in-network facilities, and requires good faith estimates for uninsured patients.
While primarily focused on medical services, its emphasis on price transparency and good faith estimates could indirectly pressure pharmacies to provide clearer out-of-pocket cost estimates, aligning with EZSCRIPTRx's cost transparency features.
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
